Skip to contentI
InspireMD, Inc.
I
NSPRInspireMD, Inc. Q4 2021 · 10-K
derived · Computed from the longer spans the company filed.
Revenue$1.38M$1.38Mderived+773.4% vs Q4 2020 Net Income-$4.10M-$4.10MderivedN/M vs Q4 2020 EPS, diluted—
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
InspireMD, Inc. · CIK 1433607 · Engraved from SEC EDGAR
Not derived. Share counts vary by quarter.
Gross Profitderived$294,000N/M Operating Incomederived-$3,931,000N/M Operating Cash Flowderived-$2,901,000N/M Free Cash Flowderived-$3,008,000N/M Margins · derivedGross margin21.3%+268.1 pt vs Q4 2020
Operating margin-284.9%+2068.3 pt vs Q4 2020
Net margin-296.9%+2141.7 pt vs Q4 2020
ended Dec 31, 2021 · filed Mar 7, 2022 · 66 d after period end